Drug level monitoring: cardiovascular drugs.
Methods for the determination of cardiovascular drugs in blood and plasma are critically reviewed with emphasis on gas and liquid chromatographic techniques. The importance of the various procedures is discussed, in particular sample work-up where the conditions for isolation and derivatization of the compounds are decisive for the accuracy and precision of the methods. Compared with other assay techniques chromatographic methods are generally to be preferred owing to their better selectivity. In the review the following groups are discussed: digitalis glycosides, antiarrhythmic agents, beta-adrenoceptor antagonists, vasodilating agents, antihypertensive compounds, and diuretics.
Ahnoff
M
M
Ervik
M
M
Lagerström
P O
PO
Persson
B A
BA
Vessman
J
J
D000317:Adrenergic alpha-Antagonists / Q000097:blood; D000318:Adrenergic beta-Agonists / Q000097:blood; D000319:Adrenergic beta-Antagonists / Q000097:blood; D000889:Anti-Arrhythmia Agents / Q000097:blood; D000959:Antihypertensive Agents / Q000097:blood; D002121:Calcium Channel Blockers / Q000097:blood; D002316:Cardiotonic Agents / Q000097:blood; D002317:Cardiovascular Agents / Q000097:blood*; D002845:Chromatography; D004071:Digitalis Glycosides / Q000097:blood; D004232:Diuretics / Q000097:blood; D006801:Humans; D006834:Hydrazines / Q000097:blood; D007124:Immunoenzyme Techniques; D008991:Monitoring, Physiologic; D009566:Nitrates / Q000097:blood; D011863:Radioimmunoassay; D013565:Sympatholytics / Q000097:blood
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D002316:Cardiotonic Agents; D002317:Cardiovascular Agents; D004071:Digitalis Glycosides; D004232:Diuretics; D006834:Hydrazines; D009566:Nitrates; D013565:Sympatholytics